indications for glp-1 agonists Receptor Exploring the Side Effects of

Han Y, Li Y, He B

2017;43(Suppl 1):2S202S7

This content cannot be viewed by non-subscribers/non-members.

This program was established to test how a category of drugs for weight management becoming available under Medicare might impact beneficiaries and the Medicare program

Why GLP-1s and Hormone Therapy Work Better Together Heres where it gets exciting: a 2024 study published in Menopause found that postmenopausal women who were on both semaglutide (the brand name for this is Ozempic) and hormone therapy (HT) lost significantly more weight than those on semaglutide alone

Its no longer enough to market a new weight-loss drug. Todays audiences from prescribers to patients expect a strategy that reflects clinical nuance, emotional complexity, and long-term value